Vice President & General Manager, EU North
B
BridgeBio PharmaBiopharmaceutical, Biotechnology
Remote - SwedenFull-TimeVp
Salary not disclosed
Apply NowOpens the employer's application page
Job Details
- Languages
- English
- Experience
- At least ten years
Requirements
- At least ten years in senior commercial leadership roles with P&L responsibility.
- At least one direct launch cycle experience within the EU North cluster (Nordics and/or UK).
- Commercial launch experience in rare disease, orphan drugs, or specialty medicines.
- Demonstrated ability to navigate complex HTA and reimbursement environments.
- Deep working knowledge of market access across multiple countries in the cluster (TLV, Nye Metoder, Medicinrådet, Fimea, NICE, SMC, NCPE).
- Experience with managed-access and risk-sharing agreements.
- Demonstrated personal track record of building and sustaining senior KOL and patient advocacy relationships in a rare disease or specialty context.
- Demonstrated ability to build and lead high-performance teams in a start-up, early-affiliate, or greenfield environment.
- Experience operating across functions and geographies within a matrixed international organization.
- Prior launch or commercialization experience in cardiology, endocrinology, or skeletal dysplasia indications.
- Demonstrated capacity to carry both a launch market and a pre-launch market concurrently.
- Background combining a larger company launch pedigree with a demonstrated capacity to operate in a lean, entrepreneurial setting.
- Fluency in English.
Responsibilities
- Lead BridgeBio’s commercial presence across the Nordic region, the United Kingdom, and Ireland.
- Carry full P&L responsibility for the cluster.
- Build the organization, shape the commercial construct, and secure external relationships.
- Lead direct launch preparation and execution across Nordic markets, including HTA and reimbursement engagement.
- Lead an active pre-launch build in the United Kingdom and Ireland, shaping market access position, cultivating clinical and patient advocacy networks, and readying the organization for launch.
- Establish the EU North operating entity, including recruitment, legal/infrastructure set-up, and governance.
- Lead launch planning and execution for infigratinib, encaleret, and subsequent pipeline assets across Nordic markets.
- Develop and execute reimbursement and pricing strategies tailored to each national authority.
- Build and sustain durable relationships with leading cardiologists, endocrinologists, and skeletal dysplasia specialists.
- Establish BridgeBio as a trusted, long-term partner to rare disease patient organizations across the cluster.
- Partner closely with Medical Affairs, Regulatory, Market Access, Finance, Legal, Compliance, and Commercial Operations at International HQ.
- Represent BridgeBio externally with integrity, including engagement with national industry associations and policy fora.
- Anticipate macroeconomic, political, regulatory, and competitive trends affecting the region.
- Reinforce BridgeBio's core values in every hire, every partnership, and every interaction.
View Full Description & ApplyYou'll be redirected to the employer's site
